Ruthless Spine has confirmed that Gad Medical Ltd. has received regulatory approval to begin sales of the RJB interoperative angle measurement instrument in Israel. This approval comes after the companies finalized distribution rights for the device, allowing hospitals and surgical centers to access a U.S.-engineered platform designed to enhance precision during implant placement. The clearance marks a significant step in expanding the availability of advanced spinal technologies in one of the region’s most innovation-focused medical markets.
Health Technology Insights: ZS Acquires Torrent Consulting to Fuel Salesforce’s Healthcare, Life Sciences AI Solutions
Manufactured in the United States, the RJB system was developed in close collaboration with spine surgeons to ensure stability, accuracy, and efficiency during procedures. The system supports a wide range of thoracic, lumbar, and sacral fusion surgeries and features a workflow tailored to the demands of complex thoracolumbar cases. Its design emphasizes reliability, multi-axial screw placement options, and minimal soft-tissue disruption, reflecting the needs voiced by clinicians during development.
Health Technology Insights: HealthLynked Names Duncan McGillivray COO to Drive Growth
The announcement follows Ruthless Spine’s successful showcase at the 2025 North American Spine Society Annual Meeting in Denver, where the company highlighted its partnership with NavJam and the RJB navigation system. This collaboration integrates high-precision navigation with a navigated Jamshidi needle, creating a cohesive solution for percutaneous access and pedicle screw placement. The navigated Jamshidi system attracted attention for its potential to simplify surgical workflows and reduce reliance on older navigation methods. Ruthless Spine was also recognized by BoneZone as one of the “10 Compelling Companies We Want to Connect With at NASS,” highlighting growing global interest in its integrated navigation-and-implant technology.
Gad Medical Ltd., as the authorized distributor, will manage local inventory, coordinate supply chains, and provide dedicated sales and technical support to hospitals across Israel. The company will also offer on-site guidance for surgeons and operating-room teams, along with structured training programs to ensure seamless adoption and maximize clinical efficiency.
David Frances, CEO of Gad Medical Ltd., commented on the launch, stating that gaining authorization to distribute the RJB system in Israel represents a major milestone. He highlighted the system’s intuitive workflow, efficiency, and suitability for complex thoracolumbar procedures. Frances expressed enthusiasm for providing Israeli hospitals with access to advanced U.S.-manufactured spinal solutions that enhance surgical precision and improve patient outcomes.
This partnership strengthens the presence of Ruthless Spine technologies in international markets and supports wider adoption of high-performance spinal instrumentation. By combining surgeon-focused design with robust technical support, the RJB system aims to deliver safer, more efficient procedures and better outcomes for patients undergoing thoracolumbar fusion surgeries.
Health Technology Insights: Omnicell Titan XT: Next-Gen Automated Medication System
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
